| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/28/2006 | WO2006101023A1 Method for producing dipeptide |
| 09/28/2006 | WO2006100986A1 Coated metal fine particle and method for producing same |
| 09/28/2006 | WO2006100816A1 Substrate having self-assembly material arranged thereon and process for production of the same |
| 09/28/2006 | WO2006100797A1 Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen |
| 09/28/2006 | WO2006100681A2 Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses |
| 09/28/2006 | WO2006100582A1 Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function |
| 09/28/2006 | WO2006100573A1 Method for producing plants with increased biomass |
| 09/28/2006 | WO2006100257A2 Vaccine and antibodies against parasitic nematodes |
| 09/28/2006 | WO2006100241A2 Method for producing polyunsaturated c20 and c22 fatty acids with at least four double bonds in transgenic plants |
| 09/28/2006 | WO2006100112A1 Plants having increased yield and a method for making the same |
| 09/28/2006 | WO2006100108A1 Fermentation process for the production of diphtheria toxin |
| 09/28/2006 | WO2006099871A1 Polypeptides and nucleic acids encoding same |
| 09/28/2006 | WO2006099747A1 Method for isolation of soluble polypeptides |
| 09/28/2006 | WO2006099706A1 Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1 |
| 09/28/2006 | WO2006099701A1 Inhibitor of endogenous human interferon - gamma |
| 09/28/2006 | WO2006099698A2 Novel anti-plgf antibody |
| 09/28/2006 | WO2006085913A3 Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| 09/28/2006 | WO2006085910A3 Endotoxin-free moraxella catarrhalis |
| 09/28/2006 | WO2006084720A3 Hpr kinase from gluconobacter oxydan |
| 09/28/2006 | WO2006079061A3 Free reactant use in nucleic acid-templated synthesis |
| 09/28/2006 | WO2006069403A3 Methods for producing soluble multi-membrane-spanning proteins |
| 09/28/2006 | WO2006068249A8 Method of obesity test and method of screening of preventive or therapeutic drug for obesity |
| 09/28/2006 | WO2006066353A9 Detection of human papilloma virus |
| 09/28/2006 | WO2006064197A3 Transgenic animals for assessing drug metabolism and toxicity |
| 09/28/2006 | WO2006059113A3 Fusion proteins comprising a non-cytotoxic protease, a targeting moiety, a protease cleavage site and a translocation domain |
| 09/28/2006 | WO2006058046A3 Apparatus and system having dry gene silencing pools |
| 09/28/2006 | WO2006052646A3 Derivation of embryonic stem cells |
| 09/28/2006 | WO2006051545A3 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 09/28/2006 | WO2006047842A3 Modified nucleosides for rna interference |
| 09/28/2006 | WO2006046042B1 Method of selecting polypeptides |
| 09/28/2006 | WO2006027696A3 Process to obtain a molecular marker to determine the sex type in borojo plants |
| 09/28/2006 | WO2006017320A3 Compositions and methods for myogenesis of fat-derived stem cells expressing telomerase and myocardin |
| 09/28/2006 | WO2006012594A3 Modification of lignin biosynthesis |
| 09/28/2006 | WO2005108573A8 METHOD TO INDUCE RNAi IN PROKARYOTIC ORGANISMS |
| 09/28/2006 | WO2005104835A3 Transgenic animals and uses thereof |
| 09/28/2006 | WO2005094516A3 A NOVEL MODULAR TYPE II RESTRICTION ENDONUCLEASE, CspCI, AND THE USE OF MODULAR ENDONUCLEASES FOR GENERATING ENDONUCLEASES WITH NEW SPECIFICITIES |
| 09/28/2006 | WO2005054280A3 Methods of producing disease-resistant animals |
| 09/28/2006 | WO2005047315A3 Optimized expression of hpv 58 l1 in yeast |
| 09/28/2006 | WO2005021776A3 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF |
| 09/28/2006 | WO2004089305A3 Heparin/heparosan synthase from p.multocida, soluble and single action catalysts thereof and methods of making and using same |
| 09/28/2006 | WO2004080404A3 Il-2 transmembrane constructs |
| 09/28/2006 | WO2004067713A3 Exogenous proteins expressed in avians and their eggs |
| 09/28/2006 | WO2004046330A3 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization |
| 09/28/2006 | WO2003076578A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/28/2006 | WO2003057857A3 Antibodies directed to pdgfd and uses thereof |
| 09/28/2006 | WO2003057841A3 Remote homologues and kinases and methods of detection |
| 09/28/2006 | WO2002083872A3 Methods and products of cleaving ssdna using oligonucleotides to form restriction sites |
| 09/28/2006 | WO2002008267A9 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/28/2006 | US20060218677 Novel gene osisap1 of rice confers tolerance to stresses and a method thereof |
| 09/28/2006 | US20060218676 Compositions and method for modulation of plant cell division |
| 09/28/2006 | US20060218675 Expression vectors for modifying oil and size phenotypes; genetic mapping variation in crop plants |
| 09/28/2006 | US20060218674 Point mutagenesis; transformed rice, corn, sorghum, millet, rye, soybean, canola, wheat, barley, oat, beans, and nuts |
| 09/28/2006 | US20060218673 Gene silencing |
| 09/28/2006 | US20060218672 Method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant |
| 09/28/2006 | US20060218671 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
| 09/28/2006 | US20060218670 Compositions and methods for production of sialylated glyoproteins in plants |
| 09/28/2006 | US20060218669 Sialylation of glycoproteins in plants |
| 09/28/2006 | US20060218668 -4Desaturases from euglena gracilis, expressing plants, and oils containing pufa |
| 09/28/2006 | US20060218667 Plant-produced recombinant aprotinin and aprotinin variants |
| 09/28/2006 | US20060218666 Nucleotide sequences encoding anthonomous toxic polypeptides from bacillus thuringiensis |
| 09/28/2006 | US20060218665 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide |
| 09/28/2006 | US20060218664 Cotton seed capable of forming a B-2-1ctHGg cotton plant having genetically controlled naturally occurring glyphosate resistance |
| 09/28/2006 | US20060218663 Using vector transformation to generate glyphosate resistant crops |
| 09/28/2006 | US20060218662 Introducing into a plant cell an expression cassette comprising a promoter operably linked to a heterologous nucleotide; transcription, gene expression; regenerating a transformed plant from plant cell; transgenic seeds; herbicide or pest resistance |
| 09/28/2006 | US20060218661 Novel sesquiterpene synthase gene and protein |
| 09/28/2006 | US20060218660 Transformation methods for Guayule using Agrobacterium and reduced light to slow metabolism and enhance recovery |
| 09/28/2006 | US20060218659 L450 polypeptide and nucleic acid encoding it; transgenic plant |
| 09/28/2006 | US20060218658 transforming a population of plant cells which comprises at least one marker protein having a direct or indirect toxic effect; genetic engineering using DNA construct capable of reducing the expression, amount, activity and/or function of the marker protein |
| 09/28/2006 | US20060218657 isolating primordial germ cells from avian embryonic gonad; and culturing in vitro for 10 days on a gonadal stroma feeder cell layer until positive for stage specific embryonic antigen-1; injecting into dorsal aorta of recipient chicken embryo without prior treatment; incubating and hatching egg |
| 09/28/2006 | US20060218656 Transgenic mice containing mGluR7 metabotropic glutamate receptor gene disruptions |
| 09/28/2006 | US20060218655 Used for identifying a drug capable of treating a B cell lymphoma, capable of depleting or killing cells expressing human CD20, or capable of inducing an Fc-mediated effector cell response; testing the safety or efficacy of anti-human CD20 therapy |
| 09/28/2006 | US20060218654 Sirna mediated gene silencing in transgenic animals |
| 09/28/2006 | US20060218652 System for gene targeting and producing stable genomic transgene insertions |
| 09/28/2006 | US20060217535 Hemipteran muscarinic receptor |
| 09/28/2006 | US20060217531 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 09/28/2006 | US20060217360 Tubulysin biosynthesis gene |
| 09/28/2006 | US20060217342 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 09/28/2006 | US20060217339 Breast cancer, prostate cancer, brain cancer, head and neck cancer, myeloma, melanoma, leukemia and lymphoma; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools. |
| 09/28/2006 | US20060217338 Influenza nucleic acids, polypeptides, and uses thereof |
| 09/28/2006 | US20060217337 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 09/28/2006 | US20060217336 Synthesizing a double stranded nucleic acid molecule used for treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 09/28/2006 | US20060217335 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 09/28/2006 | US20060217334 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 09/28/2006 | US20060217333 Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal function |
| 09/28/2006 | US20060217332 Study and interfererance, diagnosis and treatment of polyglutamine using short interfering nucleic acid for treatment of dementia or siezures or muscular dystrophy |
| 09/28/2006 | US20060217330 Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering RNAs |
| 09/28/2006 | US20060217329 Therapeutic uses of inhibitors of RTP801 |
| 09/28/2006 | US20060217327 Sirna expression system |
| 09/28/2006 | US20060217326 Group of nucleic acid fragments for prevention of hiv infection or aids and the usage thereof |
| 09/28/2006 | US20060217325 Treatment of dry eye restoring 15-lipoxygenase activity to ocular surface cells |
| 09/28/2006 | US20060217314 Feline hepatocyte growth factor |
| 09/28/2006 | US20060217294 Compounds binding to p-selectin |
| 09/28/2006 | US20060216824 Paramyxovirus vector encoding ribozyme and utilization thereof |
| 09/28/2006 | US20060216823 Method for obtaining an enriched population of siRNA-expressing cells |
| 09/28/2006 | US20060216814 Molecule detecting method, molecule counting method, molecule localization detecting method, and molecule detecting device used for them |
| 09/28/2006 | US20060216809 cGMP-binding, cGMP-specific phosphodiesterase materials and methods |
| 09/28/2006 | US20060216808 Isolated, recombinantly produced, enzymatically active hyaluronan synthase; a single protein that is a dual-action catalyst that utilizes UDP-GlcA and UDP-GlcNAc to synthesize hyaluronic acid |
| 09/28/2006 | US20060216804 Construction of new xylose utilizing saccharomyces cerevisiae strain |
| 09/28/2006 | US20060216798 Fermentation using mutant Sinorhizobium with plasmid expressing a recombinant pyridoxol 5'-phosphate synthase polypeptide; glycine resistance; increased productivity |
| 09/28/2006 | US20060216796 Method for producing l-amino acid by fermentation |